Wockhardt Shares Skyrocketed 9% on Receiving Approval for Pneumonia Antibiotic – Equitypandit
January 3, 2025January 3, 2025 Shares of Wockhardt Ltd skyrocketed 9% on 3 January after the Indian pharma authority approved an oral antibiotic for the treatment of pneumonia. The Central Drugs Standard Control Organization (CDSCO) has authorized the antibiotic Nafithromycin, which is sold under the brand name Miqnaf, as…